Undergraduate Admissions
Contact Us:
- Office of the Provost/SVPAA
- St. Thomas Hall
- 901 Linden Street, Room 5124
- Scranton, PA 18510
- The ³Ô¹ÏÌìÌÃ
- Phone: 570.941.7520
- Fax: 570-941-4386
- provost@scranton.edu
Institutional Biosafety Committee (IBC)
In compliance with federal regulations and guidelines, all research involving possible exposure to infectious agents (i.e., biohazardous materials) and recombinant DNA molecules must be registered with, reviewed and approved by the ³Ô¹ÏÌìÌÃ's Institutional Biosafety Committee (IBC).
The purpose of The National Institutes of Health (NIH) Guidelines for Research Involving Recombinant DNA Molecules is to specify practices for constructing and handling recombinant DNA molecules and organisms and viruses containing recombinant DNA molecules. Revised regulations were issued by the NIH in January 2011. Copies of the federal guidelines are available at the Office of Research and Sponsored Programs - 4th Floor O'Hara Hall.
Meeting Schedule
TBA
The IBC meets at least twice a year and reviews research by mail year-round. Information on the status of the IBC is submitted annually to the Office of Recombinant DNA Activities, NIH.
Current Members
IBC Committed Members
Academic Year 2024-2025
| Michael Landram, Ph.D., Chair | Health and Human Performance |
| John Arnott, Ph.D.* | Geisinger Commonwealth School of Medicine |
| Michael Baltrusaitis | Public Safety - Cocciardi & Associates |
| Rev. Timothy Cadigan, S.J., Ph.D. | Biology |
| Bryan Crable, Ph.D. | Biology |
| Ashley Driver, Ph.D. | Biology |
| Deborah Wardach | Lab Supervisor, Biology |
| David Marx, Ph.D. | Associate Provost Academic Affairs |
| Charles Penn* | Sanofi-Pasteur |
| *External Representative |
Biosafety Registration/Review
The Institutional Biosafety Committee Safety Manual lists the ³Ô¹ÏÌìÌà Biosafety policies as approved by the ³Ô¹ÏÌìÌà Faculty Research Committee. It is intended primarily for principal investigators (PIs), but it can also be a useful resource for ³Ô¹ÏÌìÌà teaching faculty, staff and students, and any non-³Ô¹ÏÌìÌà personnel who work in campus facilities. These policies are designed: (a) to maintain a safe working environment by protecting persons from exposure to infectious agents and organisms containing recombinant DNA; (b) to prevent environmental contamination; (c) to comply with federal regulations.
It is anticipated that most research conducted at the ³Ô¹ÏÌìÌà will fall into categories which are exempt from review according to the NIH guidelines. However, all biohazardous materials research should be registered with the IBC using the New Investigator Registration Sheet which the committee has developed. One signed hard copy of this completed document should be submitted to the IBC, Office of Research and Sponsored Programs, IMBM 200. An electronic version of the document should be sent to Dr. Michael Landram at michael.landram@scranton.edu.
The Application to use Human Blood, Blood Products, Body Fluids or Tissues in Teaching Laboratory is used to provide the IBC with the information it needs to review and evaluate laboratory exercise, to ensure that the procedures are consistent with ³Ô¹ÏÌìÌà Biosafety Policy and to ensure that faculty, staff and students are properly trained to work with and/or are protected from exposure to biohazardous materials in the media of human blood, blood products, body fluids or tissues.
The Application to use Biohazardous Material in Teaching Laboratory is used to provide the IBC with the information it needs to review and evaluate exercises, to ensure that the procedures are consistent with the ³Ô¹ÏÌìÌà Biosafety Policy and to ensure that faculty, staff and students are properly trained to work with and/or are protected from exposure to biohazardous materials.
The Application to use Recombinant DNA in Teaching Laboratory is used to provide the IBC with the information it needs to review and evaluate laboratory exercises, to ensure that the procedures are consistent with the ³Ô¹ÏÌìÌà Biosafety Policy and to ensure that faculty, staff and students are properly trained to work with and/or are protected from exposure while experimenting with recombinant DNA.
One signed hard copy of a completed application and an electronic version of the document should be sent to Dr. Michael Landram at